65.000 DRUG ABUSE

65.981             Supervised Injection Facilities MSSNY will forward a resolution to the A-17 AMA meeting requesting a comprehensive study of Supervised Injection Facilities in the United States.  (HOD 2017-160)

65.980             Overdose Prevention Sites (OPS) The Medical Society of the State of New York supports expansion of overdose prevention sites throughout New York State. The Medical Society supports a publicly disclosed report of outcomes and should provide screening, support, and referral for treatment of substance use disorders, co-occurring medical and psychiatric conditions, and provide education on

65.979             Substance Use Disorders (SUD) Medical Treatment Requirement The Medical Society of the State of New York will encourage all licensed drug treatment programs to offer treatment for Substance Use Disorders and that staff employed at these facilities be trained in the referral and provision of Medicated Assisted Treatment (MAT).  (HOD 2018-160)

65.978             Workforce Development for Addiction Treatment by Physicians The Medical Society of the State of New York supports the use of State funding to establish and support addiction medicine fellowships in New York State.  (HOD 2018-107)

65.977             Benzodiazepine and Opioid Warning The Medical Society of the State of New York will raise the awareness of its members about the increased use of illicit sedative/opioid combinations leading to addiction and overdose death.  The Medical Society of the State of New York bring this resolution to the House of Delegates of the American Medical

65.976             AMA to Analyze Benefits/Harms of Legalization of Marijuana MSSNY will forward to the AMA a request for it to review pertinent data from States that have legalized marijuana. (HOD 2019- 174 and 175)